Electromed Shares Rise on Higher Sales, Profit

Dow Jones
2025/08/27

By Katherine Hamilton

 

Electromed shares rose after the company said fiscal fourth-quarter sales and income rose.

The stock advanced 10% to $22.80 during after-hours trading Tuesday. At close, it was down 30% this year.

The health company, which specializes in technology designed to clear airways, said Tuesday its revenue increased 17% to $17.4 million in the three months ended on June 30. Its profit was $2.2 million, or 25 cents a share, compared with $1.8 million, or 20 cents a share, the year before.

Sales in Electromed's direct homecare business rose 15% primarily due to incremental referrals and approvals driven by an increase in direct sales representatives and higher revenue per approval.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

August 26, 2025 17:44 ET (21:44 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10